Advancing a broad pipeline of differentiated product candidates for chronic inflammatory diseases.
Development Pipeline
Driving meaningful advances to address chronic inflammation.
We’re committed to evolving immunology, with a pipeline that includes programs specifically targeted to address inflammatory diseases demonstrating clear, unmet needs. The disease pathways under investigation by Evommune exert influence on a multitude of disease areas, and the modulation of mast cell, sensory neuron and T-cell activity shows promise in multiple established patient populations.